Evidence map›Paper›PMID 42343087›Full record

ArticleCell discovery2026

Programmable enhancement of endogenous mRNA translation through CRISPR-guided epitranscriptomic regulation.

Yaxian Cheng, Guanglin Zhu, Xinzhi Zhou, Yiran Liu, Yingjia Pan, Xiaomeng Guo, Dongfang Li, Guoya Liao, Cui Liu, Xiaoxiang Hu and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yaxian Cheng *Xianghu Laboratory, Hangzhou, Zhejiang, China.
Guanglin Zhu *Xianghu Laboratory, Hangzhou, Zhejiang, China.
Xinzhi Zhou *College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, Zhejiang, China.
Yiran Liu *Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
Yingjia PanCollege of Chemical and Biological Engineering, Zhejiang University, Hangzhou, Zhejiang, China.
Xiaomeng GuoState Key Laboratory of Animal Biotech Breeding, China Agricultural University, Beijing, China.
Dongfang LiZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, Zhejiang, China.
Guoya LiaoDepartment of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
Cui LiuXianghu Laboratory, Hangzhou, Zhejiang, China.
Xiaoxiang HuState Key Laboratory of Animal Biotech Breeding, China Agricultural University, Beijing, China.ORCID http://orcid.org/0000-0001-7045-0283
Guoqing ShaoXianghu Laboratory, Hangzhou, Zhejiang, China.
Zhimin GuXianghu Laboratory, Hangzhou, Zhejiang, China. guzhimin2006@163.com.
Lubin LiuDepartment of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing, China. liulubin1975@126.com.
Wen JiangDepartment of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing, China. jiangwen_work@126.com.
Guo LiXianghu Laboratory, Hangzhou, Zhejiang, China. liguo@xhlab.ac.cn.

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32401241
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42343087
PMCPMC13294356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.